Blood test could give doctors early warning of kidney failure
NCT ID NCT01544231
Summary
This study aimed to see if measuring a protein called NGAL in the blood could help doctors predict which patients with severe muscle breakdown (rhabdomyolysis) would develop sudden kidney failure. Researchers followed 197 patients admitted to emergency rooms with this condition. The goal was to find a faster way to identify high-risk patients so they could receive more intensive care sooner.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for RHABDOMYOLYSIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
APHP - Groupe Hospitalier Pitié-Salpetrière
Paris, 75651, France
-
CHU de Montpellier - Hôpital Lapeyronie
Montpellier, 34295, France
-
CHU de Nice - Hôpital St-Roch
Nice, 06006, France
-
CHU de Nîmes - Hôpital Universitaire Carémeau
Nîmes, Gard, 30029, France
-
Hôpital Interarmées Sainte Anne
Toulon, 83800, France
Conditions
Explore the condition pages connected to this study.